Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-19

FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for a generic lamivudine and zidovudine tablet product, a fixed-dose combination antiretroviral us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine and Zidovudine (Lamivudine and Zidovudine)

Snippet

SUPPL AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)